1. Home
  2. FE vs RMD Comparison

FE vs RMD Comparison

Compare FE & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstEnergy Corp.

FE

FirstEnergy Corp.

HOLD

Current Price

$47.16

Market Cap

28.1B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$225.51

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FE
RMD
Founded
1996
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.1B
28.4B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
FE
RMD
Price
$47.16
$225.51
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$51.46
$292.56
AVG Volume (30 Days)
3.6M
1.4M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
3.80%
1.13%
EPS Growth
3.53
37.43
EPS
0.70
7.79
Revenue
$15,090,000,000.00
$2,957,013,000.00
Revenue This Year
$4.34
$10.60
Revenue Next Year
$3.98
$7.41
P/E Ratio
$67.14
$29.01
Revenue Growth
12.01
13.44
52 Week Low
$42.73
$180.27
52 Week High
$52.34
$293.81

Technical Indicators

Market Signals
Indicator
FE
RMD
Relative Strength Index (RSI) 42.05 62.87
Support Level $46.37 $218.39
Resistance Level $47.71 $233.75
Average True Range (ATR) 0.90 7.38
MACD -0.25 1.46
Stochastic Oscillator 17.59 93.81

Price Performance

Historical Comparison
FE
RMD

About FE FirstEnergy Corp.

FirstEnergy is an investor-owned holding company with operations across five mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: